SEARCH

SEARCH BY CITATION

References

  • 1
    Valent P, Horny HP, Bennett JM et al. Definitions and standards in the diagnosis and Treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 2007; 31:727736.
  • 2
    Mufti G, Bennett JM, Goasguen J et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of Myelodysplastic Syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ringed sideroblasts. Haematologica 2008; 93:17121727.
  • 3
    Valent P, Horny HP. Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions. Eur J Clin Invest 2009; 39:548553.
  • 4
    Brunning RD, Orazi A, Germing U et al. Myelodysplastic syndromes. In: Swerdlow SH, Campo E, Harris NL et al. eds. World Health Organization: classification of tumors of haematopoietic and lymphoid tissues, 4th edition. Lyon, France: International Agency for Research on Cancer, 2008:8893.
  • 5
    Wimazal F, Fonatsch C, Thalhammer R et al. Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface. Leuk Res 2007; 31:14611468.
  • 6
    Ando K, Kodama A, Iwabuchi T et al. Idiopathic neutropenia with fewer than 5% dysplasia may be a distinct entity of idiopathic cytopenia of undetermined significance. Ann Hematol 2010; 89:733735.
  • 7
    Shibata T, Bemey T, Reininger L et al. Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune lytic anemia by two distinct pathogenic mechanisms. Int Immunol 1990; 12:11331141.
  • 8
    He H, Shao ZH, Fu R. cytopenia related to immunity detected by modified Coombs test for measuring autoantibody of bone marrow mononuclear cells. Blood (ASH Meeting Abstract) 2002; 100:136b.
  • 9
    Fu R, Wang YH, Dong SW et al. Preliminary study of ‘Erythroblast Island’ in the bone marrow of hematocytopenic patients with positive BMMNC-Coombs test. Chin J Hematol 2010; 31:763766.
  • 10
    Liu H, Fu R, Wang Y et al. Detection and analysis of autoantigens targeted by autoantibodies in immuno-related pancytopenia. Clin Dev Immunol 2013; Article 297678.
  • 11
    Wang YH, Fu R, Shao ZH et al. Study on quantity and function of bone marrow Macrophages in patients with BMMNC-Coombs test (+) pancytopenia. Zhonghua Xue Ye Xue Za Zhi 2009; 30:538542.
  • 12
    Chen J, Fu R, Li LJ et al. Variation in complement level and its significance in cytopenia patients with positive BMMNC-Coombs. Zhonghua Xue Ye Xue Za Zhi 2009; 30:454457.
  • 13
    Liu H, Fu R, Li LJ et al. Preliminary study of the relationship between EPO receptor and autoantibody on the membrane of erythropoietic cells of the patients with BMMNC-Coombs test (+) cytopenia. Zhonghua Xue Ye Xue Za Zhi 2010; 31:413415.
  • 14
    He H, Shao ZH, Liu H et al. Immune-related pancytopenia. Chin J Hematol 2001; 22:7982.
  • 15
    Shao ZH, Fu R, Sun BZ et al. Chinese consensus statement for the diagnosis and management of aplastic anemia. Chin J Hematol. 2010; 31:790792.
  • 16
    Hanson CA, Hoyer JD, Zakko L et al. Is idiopathic cytopenia of undetermined significance (ICUS) a valid clinical concept? A longitudinal clinicopathological study. Leuk Res 2009; 33 (Suppl. 1):S109S111.
  • 17
    Fu R, Shao ZH, Liu H et al. Category, quantity and clinical significance of autoantibodies on bone marrow hematopoietic cells in patients with immunorelated cytopenia. Chin J Hematol 2003; 24:177180.
  • 18
    Fu R, Shao ZH, Liu H. Type, distribution and clinical significance of auto-antibody on bone marrow hematopoietic cells in patients with immuno-related pancytopenia. Blood 2002; 100:136b.
  • 19
    Fu R. Diagnosis and treatment of immuno-related pancytopenia. Chin J Pract Int Med 2006; 26:492496.
  • 20
    Liu H, Fu R, Shao ZH et al. Clinical analysis of 72 cases of immunorelated pancytopenia with positive BMMNC-Coombs tests. Chin J Pract Int Med 2007; 27:12701273.
  • 21
    Fu R, Shao ZH, He H et al. Quantity and apoptosis-related protein level of B lymphocyte in patients with immunorelated pancytopenia. Zhonghua Xue Ye Xue Za Zhi 2002; 23:236238.
  • 22
    Fu R, Chen J, Wang HL et al. Quantity and function of regulatory T cells in cytopenic patients with positive BMMNC-Coombs test. Zhonghua Xue Ye Xue Za Zhi 2010; 90:29892993.
  • 23
    Fu R, Wang HL, Chen J et al. Study of the quantity and function of Th17 cells in the blood cytopenic patients with positive BMMNC-Coombs test. Zhonghua Xue Ye Xue Za Zhi 2010; 31:684687.
  • 24
    Yu H, Zhang JB, Fu R, Liu H et al. Increased frequency of bone marrow T follicular helper cells in patients with immuno-related pancytopenia. Clin Dev Immunol 2013. Article 730450.
  • 25
    Sutherland DR, Kuek N, Davidson J et al. Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytometry B Clin Cytom 2007; 72B:167177.
  • 26
    Li LJ, Fu R, Wang HQ, Yue LZ et al. Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and it's clinical significances. Nat Med J China 2010; 90:672677.
  • 27
    Mel R, Galipeau PC, Prass C et al. Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res 2000; 10:11261137.
  • 28
    Pinkel D, Segraves T, Sudra D et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20:207211.